Chitosan supplementation lowers serum lipids and maintains normal calcium, magnesium, and iron status in hyperlipidemic patients

Nutrition Research

Volumn 27, Issue 3, 2007, Pages 146-151

  Liao, Fang Hsuean ^a   Shieh, Ming Jer ^a   Chang, Nen Chung ^b   Chien, Yi Wen ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Calcium; Chitosan; Cholesterol; Elderly; Human; Hyperlipidemia; Magnesium; Transferring

Indexed keywords

CALCIUM; CHITOSAN; CHOLESTEROL; HEMOGLOBIN; IRON; LIPID; MAGNESIUM; PLACEBO; POLYSACCHARIDE; TRANSFERRIN;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY FIBER; DRUG SOLUBILITY; FEMALE; HUMAN; HYPERLIPIDEMIA; IRON BLOOD LEVEL; IRON METABOLISM; LIPID BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; TRANSFERRIN BLOOD LEVEL;

EID: 33947180542     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2007.01.009     Document Type: Article

References (38)

1. Davidson M.H., Kurlandsky S.B., Kleinpell R.M., and Maki K.C. Lipid management and the elderly. Prev Cardiol 6 (2003) 128-133
2. Orzano A.J., and Scott J.G. Diagnosis and treatment of obesity in adults: an applied evidence-based review. J Am Board Fam Pract 17 (2004) 359-369
3. Scheen A.J. Management of the metabolic syndrome. Minerva Endocrinol 29 (2004) 31-45
4. Logar C.M., Herzog C.A., and Beddhu S. Diagnosis and therapy of coronary artery disease in renal failure, end-stage renal disease, and renal transplant populations. Am J Med Sci 325 (2003) 214-227
5. Thompson G.R. Management of dyslipidaemia. Heart 90 (2004) 949-955
6. Muzzarelli A.A.A. Enzymatic synthesis of chitin and chitosan, occurrence of chitin. In: Muzzarelli A.A.A. (Ed). Chitin (1977), Pergamon Press, New York 5-17
7. Arai K., Minumari K., and Fujita T. On the toxicity of chitosan. Bull Tokai Reg Fish Lab 56 (1968) 889-892
8. Furda I. Aminopolysaccharides-their potential as dietary fiber. In: Furda I. (Ed). Unconventional sources of dietary fiber. ACS Symposium Series 214 (1983), American Chemical Society, Washington (DC) 105-122
9. Koide S.S. Chitin-chitosan: properties, benefits and risks. Nutr Res 18 (1998) 1091-1101
10. Sugano M., Fujikawa Y., Hiratsuji K., Nakashima N., Fukuda N., and Hasegawa Y. A novel use of chitosan as a hypocholesterolemic agent in rats. Am J Clin Nutr 33 (1980) 787-793
11. Maezaki Y., Tsuji K., Nakagawa Y., Kawai Y., Akimoto M., Tsugita T., et al. Hypocholesterolemic effect of chitosan in adult males. Biosci Biotechnol Biochem 57 (1993) 1439-1444
12. Takimoto H., Hasegawa M., Yagi K., Nakamura T., Sakaeda T., and Hirai M. Proapoptotic effect of a dietary supplement: water soluble chitosan activates caspase-8 and modulating death receptor expression. Drug Metab Pharmacokinet 19 (2004) 76-82
13. Kim M.S., Sung M.J., Seo S.B., Yoo S.J., Lim W.K., and Kim H.M. Water-soluble chitosan inhibits the production of pro-inflammatory cytokine in human astrocytoma cells activated by amyloid beta peptide and interleukin-1beta. Neurosci Lett 321 (2002) 105-109
14. Richardson S.C., Kolbe H.V., and Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int J Pharm 178 (1999) 231-243
15. Reinhold J.G., Faradji B., Abadi P., and Ismail-Beigi F. Decreased absorption of calcium, magnesium, zinc and phosphorus by humans due to increased fiber and phosphorus consumption of wheat bread. J Nutr 106 (1976) 493-503
16. Deuchi K., Kanauchi O., Shizukuishi M., and Kobayashi E. Continuous and massive intake of chitosan affects mineral and fat-soluble vitamin status in rats fed on a high-fat diet. Biosci Biotechnol Biochem 59 (1995) 1211-1216
17. Wada M., Nishimura Y., Watanabe Y., Takita T., and Innami S. Accelerating effect of chitosan intake on urinary calcium excretion by rats. Biosci Biotechnol Biochem 61 (1997) 1206-1208
18. Yang C.Y., Oh T.W., Nakajima D., Maeda A., Naka T., Kim C.S., et al. Effects of habitual chitosan intake on bone mass, bone-related metabolic markers and duodenum CaBP D9K mRNA in ovariectomized SHRSP rats. J Nutr Sci Vitaminol (Tokyo) 48 (2002) 371-378
19. International Task Force for Prevention of Coronary Heart Disease. Prevention of coronary heart disease: scientific background and new clinical guidelines. Nutr Metab Cardiovasc Dis 2 (1992) 113-156
20. Allain C.C., Poon L.S., Chan C.S., Richmond W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
21. Spayd R.W., Bruschi B., Burdick B.A., Dappen G.M., Eikenberry J.N., Esders T.W., et al. Multilayer film elements for clinical analysis: applications to representative chemical determinations. Clin Chem 24 (1978) 1343-1350
22. Rifai N., Warnick G.R., McNamara J.R., Belcher J.D., Grinstead G.F., and Frantz Jr. I.D. Measurement of low-density-lipoprotein cholesterol in serum: a status report. Clin Chem 38 (1992) 150-160
23. Sugiuchi H., Uji Y., Okabe H., Irie T., Uekama K., Kayahara N., et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem 41 (1995) 717-723
24. Ohno N., and Sakai T. Spectrophotometric determination of iron in boiler and well water by flow injection analysis using 2-nitroso-5-(N-propyl-N-sulfopropylamino) phenol. Analyst 112 (1987) 1127
25. Sugano M., Fujikawa T., Hiratsuji Y., and Hasegawa Y. Hypocholesterolemic effects of chitosan in cholesterol-fed rats. Nutr Rep Int 18 (1978) 531-537
26. Fukada Y., Kimura K., and Ayaki Y. Effect of chitosan feeding on intestinal bile acid metabolism in rats. Lipid 26 (1991) 395-399
27. Gallaher D.D., Gallaher C.M., Mahrt G.J., Carr T.P., Hollingshead C.H., Hesslink R., et al. A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. J Am Coll Nutr 21 (2002) 428-433
28. Council on Scientific Affairs. Dietary fiber and health. J Am Med Assoc 262 (1989) 542-546
29. Kishimoto Y., Wakabayashi S., and Takeda H. Hypocholesterolemic effect of dietary fiber: relation to intestinal fermentation and bile acid excretion. J Nutr Sci Vitaminol (Tokyo) 41 (1995) 151-161
30. Holme I. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. Circulation 82 (1990) 1916-1924
31. The expert's panel. Summary of the national guidelines for the diagnosis and management of lipid disorders in Taiwan. Chin Med J 55 (1995) 1-14
32. Ausar S.F., Morcillo M., Leon A.E., Ribotta P.D., Masih R., Vilaro Mainero M., et al. Improvement of HDL- and LDL-cholesterol levels in diabetic subjects by feeding bread containing chitosan. J Med Food 6 (2003) 397-399
33. Jing S.B., Li L., Ji D., Takiguchi Y., and Yamaguchi T. Effect of chitosan on renal function in patients with chronic renal failure. J Pharm Pharmacol 49 (1997) 721-723
34. Ormrod D.J., Holmes C.C., and Miller T.E. Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis 138 (1998) 329-334
35. Weaver C.M. Assessing calcium status and metabolism. J Nutr 120 (1990) 1470-1473
36. Wannasilp N., Poungvarin N., Pokum S., Leowattana W., and Mahanonda N. Serum magnesium in Thai coronary artery disease patients. J Med Assoc Thai 84 (2001) S645-S649
37. Herbert V. Everyone should be tested for iron disorders. J Am Diet Assoc 92 (1992) 1502-1509
38. Baba Y., Noma H., Nakayama R., and Matsushita Y. Preparation of chitosan derivatives containing methylthiocarbamoyl and phenylthiocarbamoyl groups and their selective adsorption of copper(II) over iron(III). Anal Sci 18 (2002) 359-361